These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8159859)

  • 1. Ticlopidine hydrochloride: its current use in cerebrovascular disease.
    Bronstein KS; Chadwick LR
    Rehabil Nurs; 1994; 19(1):17-20. PubMed ID: 8159859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke prevention in women: role of aspirin versus ticlopidine.
    Hershey LA
    Am J Med; 1991 Sep; 91(3):288-92. PubMed ID: 1832517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy in the treatment of cerebrovascular disease.
    Couch JR
    Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticlopidine hydrochloride.
    Blissitt PA
    J Neurosci Nurs; 1992 Oct; 24(5):296-300. PubMed ID: 1402156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticlopidine: a new antiplatelet agent for the secondary prevention of stroke.
    Murray JC; Kelly MA; Gorelick PB
    Clin Neuropharmacol; 1994 Feb; 17(1):23-31. PubMed ID: 8149356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ticlopidine for prevention of stroke.
    Albers GW
    Stroke; 1992 Jun; 23(6):912-6. PubMed ID: 1595115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticlopidine hydrochloride and prevention of stroke.
    Macko R
    West J Med; 1993 Aug; 159(2):182. PubMed ID: 8212686
    [No Abstract]   [Full Text] [Related]  

  • 9. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.
    McTavish D; Faulds D; Goa KL
    Drugs; 1990 Aug; 40(2):238-59. PubMed ID: 2226215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy in the prevention of stroke.
    Easton JD
    Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine: a new antiplatelet agent for cerebrovascular disease.
    Robert S; Miller AJ; Fagan SC
    Pharmacotherapy; 1991; 11(4):317-22; discussion 322-5. PubMed ID: 1923914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients.
    Oster G; Huse DM; Lacey MJ; Epstein AM
    Stroke; 1994 Jun; 25(6):1149-56. PubMed ID: 8202972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy in cerebrovascular disorders.
    Weber R; Brenck J; Diener HC
    Handb Exp Pharmacol; 2012; (210):519-46. PubMed ID: 22918745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.
    Noble S; Goa KL
    Drugs Aging; 1996 Mar; 8(3):214-32. PubMed ID: 8720746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine hydrochloride use and threatened stroke.
    Rothrock JF; Hart RG
    West J Med; 1994 Jan; 160(1):43-7. PubMed ID: 8128701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
    Harbison JW
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
    Bhatt DL; Kapadia SR; Yadav JS; Topol EJ
    Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.
    Bellavance A
    Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.
    Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B
    N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.